Agios Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Agios Pharmaceuticals has a total shareholder equity of $1.6B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.8B and $165.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.00b |
| Equity | US$1.63b |
| Total liabilities | US$165.12m |
| Total assets | US$1.79b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AGIO *'s short term assets ($1.1B) exceed its short term liabilities ($119.5M).
Long Term Liabilities: AGIO *'s short term assets ($1.1B) exceed its long term liabilities ($45.7M).
Debt to Equity History and Analysis
Debt Level: AGIO * is debt free.
Reducing Debt: AGIO * had no debt 5 years ago.
Debt Coverage: AGIO * has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AGIO * has no debt, therefore coverage of interest payments is not a concern.